Quantification of allergenic urushiols in extracts of Ginkgo biloba leaves, in simple one-step extracts and refined manufactured material (EGb 761)

Phytochemical Analysis

Volumn 15, Issue 1, 2004, Pages 1-8

  Schötz, Karl ^a  

^a DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Allergens; Cardanols; Cardols; Ginkgo biloba; Ginkgolic acids; GS MS; Phyto pharmaceuticals; Urushiols

Indexed keywords

ACETONE; EXTRACTION; QUALITY CONTROL;

ALKYLPHENOLS; CARDANOLS; CARDOL; GINKGO BILOBA; GINKGOBILOBA LEAVES; GINKGOLIC ACID; GS-MS; PHYTO-PHARMACEUTICAL; SIMPLE++; URUSHIOL;

ALLERGENS;

ACETONE; ALKYLPHENOL; ALLERGEN; ANACARDIC ACID; BENZENE DERIVATIVE; CATECHOL DERIVATIVE; GINKGO BILOBA EXTRACT; URUSHIOL;

ALLERGENICITY; ANALYTIC METHOD; ARTICLE; BRAIN ISCHEMIA; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DEMENTIA; DERMATITIS; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; GINKGO BILOBA; MASS SPECTROMETRY; MUTAGENICITY; PERIPHERAL ISCHEMIA; PLANT LEAF; RELIABILITY; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; TUMOR PROMOTION;

GINKGO BILOBA; GINKGOACEAE;

EID: 1042268843     PISSN: 09580344     EISSN: None     Source Type: Journal    
DOI: 10.1002/pca.733     Document Type: Article

References (43)

1. Baer H, Watkins RC, Kurtz P, Byck JS, Dawson CR. 1967. Delayed contact sensitivity to catechols. 2. Cutaneous toxicity of catechols chemically related to the active principles of poison ivy. J Immunol 99: 365-369.
2. Balint AV, Dawson JH, Dawson CR. 1975. A spectroscopic and chromatographic investigation of the behaviour of 3-pentadecylcatechol (PDC) in various solvents under aerobic conditions. Anal Biochem 66: 340-352.
3. Barr JR, Murty VS, Yamaguchi K, Singh S, Smith DH, Hecht SM. 1988. 5-Alkylresorcinols from Hakea amplexicaulis that cleave DNA. Chem Res Toxicol 1: 204-207.
4. Blumenthal M. (ed.). 1998. The Complete German Commission E Monographs. American Botanical Council: Austin, TX.
5. Cartayrade A, Bourgeois G, Balz J-P, Carde J-P. 1990. The secretory apparatus of Ginkgo biloba: structure, differentiation and analysis of the secretory product. Trees 4: 171-178.
6. Chiu AE, Lane AT, Kimball AB. 2002. Diffuse morbilliform eruption after consumption of Ginkgo biloba supplement. J Am Acad Dermatol 46: 145-146.
7. Deszcz L, Kozubek A. 2000. Higher cardol homologues (5-alkylresorcinols) in rye seedlings. Biochim Biophys Acta 1483: 241-250.
8. Deutsches Arzneibuch 2000. 2001. German Pharmacopoeia 2000. Deutscher Apotheker Verlag: Stuttgart.
9. Du YOR, Iwatsuki H, Kumanotani J. 1984. High-resolution gas-liquid chromatographic analysis of urushiol of the LAC tree, Rhus vernicifera, without derivatisation. J Chromatogr 295: 179-188.
10. ElSohley MA, Turner CE. 1980. GLC analysis of poison ivy and poison oak urushiol components in vegetable oil preparations. J Pharm Sci 69: 587-589.
11. ElSohley MA, Adawadkar PD, Benigni DA, Watson ES, Little TL. 1986. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes. J Med Chem 29: 606-611.
12. Evans FJ, Schmidt RJ. 1980. Plants and plant products that induce contact dermatitis. Planta Med 38: 289-316.
13. Franke K, Masaoud M, Schmidt J. 2001. Cardanols from leaves of Rhus thyrsiflora. Planta Med 67: 477-9.
14. Fürstner A, Seidel G. 1997. Shortcut syntheses of naturally occurring 5-alkylresorcinols with DNA-cleaving properties. J Org Chem 62: 2332-6.
15. Gellerman JL, Schlenk H. 1968. Methods for determination and isolation of anacardic acids. Anal Chem 40: 739-743.
16. Gellerman JL, Anderson WH, Schlenk H. 1976. 6-(Pentadec-8-enyl)-2,4-dihydroxybenzoic acid from seeds of Ginkgo biloba. Phytochemistry 15: 1959-1961.
17. Hausen B, Vieluf K. 1997. Allergiepflanzen, Pflanzenallergene. Ecomed/Nikol: Hamburg.
18. Hauser FM, Pogany SA. 1980. 2-Hydroxy-6-methylbenzoic acid derivatives. Synthesis 814-815.
19. Irie J, Murata M, Homma S. 1996. Glycerol-3-phosphate dehydrogenase inhibitors; anacardic acids from Ginkgo biloba. Biosci Biotechnol Biochem 60: 240-243.
20. Itokawa H, Totsuka N, Nakahara K, Takeya K, Lepoittevin J-P, Asakawa Y. 1987. Anti-tumour principles from Ginkgo biloba L. Chem Pharm Bull 35: 3016-3020.
21. Itokawa H, Totsuka N, Nakahara K, Maezuru M, Takeya. K., Kondo M, Inamatsu M, Morita H. 1989. A quantitative structure-activity relationship for anti-tumour activity of long-chain phenols from Ginkgo biloba L. Chem Pharm Bull 37: 1619-1621.
22. Jaggy H, Koch E. 1997. Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie 52: 735-738.
23. Jenke DR. 1996a. Chromatographic method validation: a review of current practices and procedures. 1. General concepts and guidelines. J Liq Chromatogr Relat Technol 19: 719-736.
24. Jenke DR. 1996b. Chromatographic method validation: a review of current practices and procedures. 2. Guidelines for primary validation parameters. J Liq Chromatogr Relat Technol 19: 737-757.
25. Jenke DR. 1996c. Chromatographic method validation: a review of current practices and procedures. 3. Ruggedness, revalidation and system suitability. J Liq Chromatogr Relat Technol 19: 1873-1891.
26. Kawamura J. 1928. Ueber die chemischen Bestandteile der Frucht von Ginkgo biloba (1. Mitteilung). Japan J Chem 3: 89.
27. Kiong LS, Tyman JHP. 1981. Long chain phenols. 18. Conversion of anacardic acid into urushiol. J Chem Soc Perkin 1: 1942-1952.
28. Kozubek A, Tyman JHP. 1999. Resorcinolic lipids, the natural non-isoprenoid phenolic amphiphiles and their biological activity. Chem Rev 99: 1-25.
29. Kubo I, Kinst-Hori I, Yokokawa Y. 1994. Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod 57: 545-551.
30. Le Bars PL, Kieser M, Itil KZ. 2000. A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 11: 230-237.
31. Lee JS, Cho YS, Park EJ, Kim J, Oh WK, Lee HS, Ahn JS. 1998. Phospholipase Cγ1 inhibitory principles from the sarcotestas of Ginkgo biloba. J Nat Prod 61: 867-871.
32. Lepoittevin J-P, Benezra C, Asakawa Y. 1989. Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol. Arch Dermatol Res 281: 227-230.
33. Liebgott T, Miollan M, Berchadsky Y, Drieu K, Culcasi M, Pietri S. 2000. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res Cardiol 95: 368-377.
34. Mossabeb R, Kraft D, Valenta R. 2001. Evaluation of the allergenic potential of Ginkgo biloba extracts. Wien Klin Wochenschr 113: 580-587.
35. Sasseville D, Nguyen KH. 1995. Allergic contact dermatitis from Rhus toxicodendron in a phytotherapeutic preparation. Contact Dermatitis 32: 182-183.
36. Schötz K. 2002. Detection of allergenic urushiols in Ginkgo biloba leaves. Pharmazie 57: 508-510.
37. Siegers CG. 1999. Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 64: 281-283.
38. Stahl E, Keller K, Blinn C. 1983. Cardanol, a skin irritant in pink pepper. Planta Med 48: 5-9.
39. Tyman JHP. 1997. Non-isoprenoid long-chain phenols. Chem Soc Rev 8: 499-537.
40. Verotta L, Morazzoni P, Peterlongo F. 2000. Occurrence and analysis of alkylphenols in Ginkgo biloba. In Ginkgo biloba, van Beek TA. (ed.). Harwood: Amsterdam; 203-213.
41. Westendorf J, Regan J. 2000. Induction of DNA strand-breaks in primary rat hepatocytes by ginkgolic acids. Pharmazie 55: 864-865.
42. Zarnowska ED, Zarnowski R, Kozubek A. 2000. Alkylresorcinols in fruit pulp and leaves of Ginkgo biloba L. Z Naturforsch [C] 55: 881-885.
43. Zehnter R, Gerlach H. 1995. Synthesis of anacardic acids. Justus Liebigs Ann Chem: 2209-20.